South & Central America Nerve Repair & Regeneration Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Neurostimulation & Neuromodulation Devices {Internal Neurostimulation Devices [Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation] and External Neurostimulation Devices [Transcutaneous Electrical Nerve Stimulation Devices, Transcranial Magnetic Stimulation Devices, Respiratory Electrical Stimulation Devices]} and Biomaterials), and Application (Neurostimulation & Neuromodulation Applications {Internal neurostimulation & neuromodulation, and External neurostimulation & neuromodulation}, and Nerve Repair & Regeneration Applications {Direct Nerve Repair/Neurorrhaphy [Epineural Repair, Perineural Repair, and Group Fascicular Repair], Nerve Grafting [Autografts, Allografts, and Xenografts], and Stem cell therapy})
The nerve repair & regeneration market in South & Central America is expected to grow from US$ 343.17 million in 2022 to US$ 583.16 million by 2028; it is estimated to grow at a CAGR of 9.2% from 2022 to 2028.
Advancements in Stem Cell Therapy for Nerve Repair & Regeneration to Bolster Nerve Repair & Regeneration Market Growth in South & Central America during Forecast Period
Cell-based therapy improves the functional clinical outcome after nerve injury. In recent years, the technology in constructing tissue-engineered nerve grafts has seen significant progress. Incorporating stem cells such as embryonic stem cells, neural stem cells, bone marrow mesenchymal stem cells, adipose stem cells, skin-derived precursor stem cells, and induced pluripotent stem cells have enhanced the therapeutic effects of tissue-engineered nerve grafts. The high effectiveness of stem cells enlightens the optimistic future of the large-scale clinical use of stem cells. Incorporating stem cells as seed cells into the biomaterial-based scaffolds increases the effectiveness of tissue-engineered nerve grafts and boosts the regenerative process. Numerous stem cells such as neural stem cells, embryonic stem cells, adipose stem cells, skin-derived precursor stem cells, induced pluripotent stem cells, and bone marrow mesenchymal stem cells have been used in neural tissue engineering. Cell-based therapy improves neural regeneration after peripheral nerve injuries (PNIs); it has introduced a new perspective to regenerative medicine. The main mechanisms that highlight the valuable effects of stem cells on neural regeneration are augmenting axonal regeneration, remyelination, and muscle mass preservation. Thus, the advancements in stem cell therapy for nerve repair & regeneration are likely to offer growth opportunities for the nerve repair & regeneration market players operating in South & Central America.
Market Overview
The South & Central America nerve repair & regeneration market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil accounted for a significant share of the market in 2021, followed by Argentina. The nerve repair & regeneration market in South & Central America is expected to grow due to the rising cases of Parkinson’s and Alzheimer’s diseases, a surge in the geriatric population, and a rising number of developments by various organizations in countries across the region.
South & Central America Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Nerve Repair & Regeneration Market Segmentation
The South & Central America nerve repair & regeneration market is bifurcated on the basis of product and application.
Based on product, the South & Central America nerve repair & regeneration market is segmented into neurostimulation and neuromodulation devices and biomaterials. The neurostimulation and neuromodulation devices segment accounted for a larger market share in 2022. Based on application, the South & Central America nerve repair & regeneration market is bifurcated into neurostimulation & neuromodulation applications and nerve repair & regeneration applications. The nerve repair & regeneration applications segment held a larger market share in 2022. Based on country, the South & Central America nerve repair & regeneration market is segmented into Brazil, Argentina, and the Rest of South & Central America. Further, Brazil dominated the market in 2022. Axogen Corporation, Boston Scientific Corporation, Integra LifeSciences, Medtronic, Abbott Laboratories, Stryker Corporation, Neuronetics, LivaNova PLC, Baxter, and Polyganics BV are the leading companies operating in the nerve repair & regeneration market in South & Central America.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe laboratory information system (LIS) market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe laboratory information system (LIS) market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the laboratory information system (LIS) market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook